UTI Healthcare Fund - Regular Plan - Growth Option
(Erstwhile UTI Pharma & Healthcare Fund-Growth Option)
| Category: Equity: Sectoral-Pharma and Healthcare |
| Launch Date: 01-08-2005 |
| Asset Class: Equity |
| Benchmark: S&P BSE Healthcare TRI |
| Expense Ratio: 2.55% As on (31-01-2020) |
| Status: Open Ended Schemes |
| Minimum Investment: 5000.0 |
| Minimum Topup: 1000.0 |
| Total Assets: 390.37 Cr As on (29-02-2020) |
| Turn over: 46% | Exit Load: 1% for redemption within 364 days |
76.5369
0.6 (0.7792%)
10.32%
S&P BSE Healthcare TRI 9.38%
PERFORMANCE
Fund Multiplier
Time it would have taken to make your money double (2x), quadruple (4x) and quintuple (5x)
Investment Objective
An open-end fund which exclusively invests in the equities of the pharma & healthcare sector companies. This fund is one of the growth sector fund s aiming to invest in companies engaged in business of manufacturing and marketing of bulk drug, formulations and health care products and service.
Current Asset Allocation (%)
Indicators
| Volatility | 15.99 |
| Sharp Ratio | 0.16 |
| Alpha | -3.52 |
| Beta | 1.04 |
| Yield to Maturity | - |
| Average Maturity | - |
PEER COMPARISON
| Scheme Name | Inception Date |
1 Year Return(%) |
2 Year Return(%) |
3 Year Return(%) |
5 Year Return(%) |
10 Year Return(%) |
|---|---|---|---|---|---|---|
| UTI Healthcare Fund - Regular Plan - Growth Option | 01-08-2005 | -9.18 | -4.11 | -4.86 | -4.63 | 8.42 |
| DSP Healthcare Fund - Regular Plan - Growth | 05-11-2018 | 1.1 | - | - | - | - |
| Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth | 05-07-2019 | - | - | - | - | - |
| Mirae Asset Healthcare Fund -Regular Growth | 20-07-2018 | -2.43 | - | - | - | - |
| IDBI Healthcare Fund - Regular Plan - Growth | 22-02-2019 | -3.79 | - | - | - | - |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | 28-12-2015 | -4.48 | 0.26 | -1.91 | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 14-07-1999 | -7.49 | -4.24 | -7.22 | -4.42 | 11.34 |
| Nippon India Pharma Fund-Growth Plan-Growth Option | 01-06-2004 | -7.61 | 1.28 | 0.71 | 0.43 | 11.06 |
| ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option | 05-07-2018 | -8.02 | - | - | - | - |
Scheme Characteristics
Minimum investment in equity & equity related instruments of a particular sector/ particular theme - 80% of total assets.
Riskometer
PORTFOLIO
Market Cap Distribution
Small Cap
13.61%
Others
1.86%
Large Cap
46.4%
Mid Cap
38.13%
Scheme Documents
Tax Benefits of investing in this fund
Long term capital gains (LTCG) tax @10% (plus surcharge, if applicable and cess) without indexation if units held for more than 12 months#
Short term capital gains (STCG) tax @ 15% (plus surcharge, if applicable and cess) if units are held for less than 12 months.
Investor does not pay any tax on dividends but a Dividend Distribution Tax (DDT) is deducted at source @11.648% (10% + 12% surcharge + 4% Health & education cess) **
# Capital gain accrued up to January 31st 2018 is exempt from LTCG tax in respect of units acquired before January 31, 2018 & redeemed on or after April 1, 2018. ** The DDT is to be paid by the mutual fund
